{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:15:52Z","timestamp":1757700952594},"reference-count":0,"publisher":"Academy of Managed Care Pharmacy","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMCP"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.18553\/jmcp.2003.9.2.150","type":"journal-article","created":{"date-parts":[[2016,2,21]],"date-time":"2016-02-21T14:30:34Z","timestamp":1456065034000},"page":"150-158","source":"Crossref","is-referenced-by-count":17,"title":["Modeling the Annual Costs of Postmenopausal Prevention Therapy: Raloxifene, Alendronate, or Estrogen-Progestin Therapy"],"prefix":"10.18553","volume":"9","author":[{"given":"C. Daniel","family":"Mullins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Ohsfeldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7818","container-title":["Journal of Managed Care Pharmacy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2016,2,21]],"date-time":"2016-02-21T14:30:36Z","timestamp":1456065036000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jmcp.org\/doi\/10.18553\/jmcp.2003.9.2.150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["10.18553\/jmcp.2003.9.2.150"],"URL":"https:\/\/doi.org\/10.18553\/jmcp.2003.9.2.150","relation":{},"ISSN":["1083-4087","1944-706X"],"issn-type":[{"value":"1083-4087","type":"print"},{"value":"1944-706X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}